Similar articles for PMID: 11010055

Year	Number of Results
1995	3
1996	5
1997	5
1998	4
1999	4
2000	7
2001	5
2002	6
2003	3
2004	7
2005	8
2006	6
2007	5
2008	3
2009	4
2010	2
2011	5
2012	2
2013	2
2014	2
2015	1
2019	2
2020	1
2021	1
2022	4
2023	3
2024	0

1

Use of ambulatory blood pressure monitoring to compare antihypertensive efficacy and safety of two angiotensin II receptor antagonists, losartan and valsartan. Losartan Trial Investigators.

Monterroso VH, Rodriguez Chavez V, Carbajal ET, Vogel DR, Aroca Martinez GJ, Garcia LH, Cuevas JH, Lara Teran J, Hitzenberger G, Leao Neves P, Middlemost SJ, Dumortier T, Bunt AM, Smith RD. Monterroso VH, et al. Adv Ther. 2000 Mar-Apr;17(2):117-31. doi: 10.1007/BF02854844. Adv Ther. 2000. PMID: 11010055 Clinical Trial.

2

Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: data from a multicenter, randomized, double-blind, 12-week trial.

Elliott WJ, Calhoun DA, DeLucca PT, Gazdick LP, Kerns DE, Zeldin RK. Elliott WJ, et al. Clin Ther. 2001 Aug;23(8):1166-79. doi: 10.1016/s0149-2918(01)80099-0. Clin Ther. 2001. PMID: 11558856 Clinical Trial.

3

Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan.

Smith DH, Dubiel R, Jones M. Smith DH, et al. Am J Cardiovasc Drugs. 2005;5(1):41-50. doi: 10.2165/00129784-200505010-00006. Am J Cardiovasc Drugs. 2005. PMID: 15631537 Clinical Trial.

4

Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ.

Duprez D, Ferdinand K, Purkayastha D, Samuel R, Wright R. Duprez D, et al. Vasc Health Risk Manag. 2011;7:701-8. doi: 10.2147/VHRM.S25743. Epub 2011 Nov 24. Vasc Health Risk Manag. 2011. PMID: 22174580 Free PMC article. Clinical Trial.

5

Effect on blood pressure control of switching from valsartan monotherapy to losartan/hydrochlorothiazide in Asian patients with hypertension: results of a multicentre open-label trial.

Watanabe LA, Wei M, Sun N, Kim D, Chiang CE, Ke Y, Tseng CD, Coloma R, Vala M, Massaad R, Feig P, Guptha S. Watanabe LA, et al. Curr Med Res Opin. 2006 Oct;22(10):1955-64. doi: 10.1185/030079906X132514. Curr Med Res Opin. 2006. PMID: 17022855 Clinical Trial.

6

Ambulatory blood pressure response to once-daily fimasartan: an 8-week, multicenter, randomized, double-blind, active-comparator, parallel-group study in Korean patients with mild to moderate essential hypertension.

Lee H, Kim KS, Chae SC, Jeong MH, Kim DS, Oh BH. Lee H, et al. Clin Ther. 2013 Sep;35(9):1337-49. doi: 10.1016/j.clinthera.2013.06.021. Epub 2013 Aug 7. Clin Ther. 2013. PMID: 23932463 Clinical Trial.

7

Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension. Losartan Trial Investigators.

Manolis AJ, Grossman E, Jelakovic B, Jacovides A, Bernhardi DC, Cabrera WJ, Watanabe LA, Barragan J, Matadamas N, Mendiola A, Woo KS, Zhu JR, Mejia AD, Bunt T, Dumortier T, Smith RD. Manolis AJ, et al. Clin Ther. 2000 Oct;22(10):1186-203. doi: 10.1016/s0149-2918(00)83062-3. Clin Ther. 2000. PMID: 11110230 Clinical Trial.

8

A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension.

Hedner T, Oparil S, Rasmussen K, Rapelli A, Gatlin M, Kobi P, Sullivan J, Oddou-Stock P. Hedner T, et al. Am J Hypertens. 1999 Apr;12(4 Pt 1):414-7. doi: 10.1016/s0895-7061(99)00082-5. Am J Hypertens. 1999. PMID: 10232502 Clinical Trial.

9

A randomized, double-blind comparison of the antihypertensive efficacy and safety of once-daily losartan compared to twice-daily captopril in mild to moderate essential hypertension.

Roca-Cusachs A, Oigman W, Lepe L, Cifkova R, Karpov YA, Harron DW. Roca-Cusachs A, et al. Acta Cardiol. 1997;52(6):495-506. Acta Cardiol. 1997. PMID: 9542575 Clinical Trial.

10

A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.

Littlejohn T, Mroczek W, Marbury T, VanderMaelen CP, Dubiel RF. Littlejohn T, et al. Can J Cardiol. 2000 Sep;16(9):1123-32. Can J Cardiol. 2000. PMID: 11021956 Clinical Trial. English, French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

97 results

Results by year